Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.71 - $12.06 $2,855 - $6,030
-500 Reduced 33.33%
1,000 $6,000
Q1 2024

May 15, 2024

SELL
$8.87 - $14.55 $113,535 - $186,240
-12,800 Reduced 89.51%
1,500 $18,000
Q4 2023

Feb 14, 2024

BUY
$8.16 - $13.13 $43,248 - $69,589
5,300 Added 58.89%
14,300 $177,000
Q3 2023

Nov 14, 2023

BUY
$12.15 - $18.33 $38,880 - $58,655
3,200 Added 55.17%
9,000 $112,000
Q2 2023

Aug 14, 2023

BUY
$16.64 - $18.88 $28,288 - $32,096
1,700 Added 41.46%
5,800 $102,000
Q1 2023

May 15, 2023

BUY
$15.89 - $21.05 $63,560 - $84,200
4,000 Added 4000.0%
4,100 $69,000
Q4 2022

Feb 14, 2023

BUY
$16.2 - $21.11 $1,620 - $2,111
100 New
100 $1,000

Others Institutions Holding FNA

About Paragon 28, Inc.


  • Ticker FNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 76,775,800
  • Market Cap $527M
  • Description
  • Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navic...
More about FNA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.